Da‐Qiang Li
- Cancer Research top 1%
- Molecular Biology top 2%
- Ubiquitin and proteasome pathways 17
- RNA modifications and cancer 15
- DNA Repair Mechanisms 12
- Epigenetics and DNA Methylation 10
- RNA Research and Splicing 10
- Histone Deacetylase Inhibitors Research 9
- Genomics and Chromatin Dynamics 9
- Oncology top 2%
- Cancer-related Molecular Pathways 9
- Cell Biology top 5%
- Co-authors
- Rakesh KumarYi‐Zhou JiangXi JinXin HuDing MaZhi‐Ming ShaoSujit S. NairYi Xiao
- Journals
- Journal of Biological Chemistry (6 papers)Cancer Research (6 papers)Cancer Letters (4 papers)
- Partner nations
- ChinaUnited StatesLaos
In The Last Decade
Da‐Qiang Li
83 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Cancer Research 1.2k
- Molecular Biology 3.1k
- Oncology 1.1k
- Cell Biology 454
- Pulmonary and Respiratory Medicine 731
Countries citing papers authored by Da‐Qiang Li
This map shows the geographic impact of Da‐Qiang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Da‐Qiang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Da‐Qiang Li more than expected).
Fields of papers citing papers by Da‐Qiang Li
This network shows the impact of papers produced by Da‐Qiang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Da‐Qiang Li. The network helps show where Da‐Qiang Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Da‐Qiang Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 8 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 28 | |
| 7 | 2023 | 6 | |
| 8 | 2022 | 43 | |
| 9 | 2022 | 37 | |
| 10 | 2021 | 62 | |
| 11 | 2021 | 42 | |
| 12 | 2021 | 41 | |
| 13 | 2020 | 28 | |
| 14 | 2019 | 96 | |
| 15 | 2018 | 80 | |
| 16 | 2018 | 83 | |
| 17 | 2018 | 65 | |
| 18 | 2016 | 0 | |
| 19 | 2012 | 65 | |
| 20 | 2009 | 412 |
About Da‐Qiang Li
Da‐Qiang Li is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 87 papers that have together received 4.5k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (17 papers), RNA modifications and cancer (15 papers), DNA Repair Mechanisms (12 papers), Epigenetics and DNA Methylation (10 papers), RNA Research and Splicing (10 papers), Histone Deacetylase Inhibitors Research (9 papers), Cancer-related Molecular Pathways (9 papers) and Genomics and Chromatin Dynamics (9 papers). The work is most often cited by research in Cancer Research (1.2k citations), Molecular Biology (3.1k citations) and Oncology (1.1k citations). Da‐Qiang Li has collaborated with scholars based in China, United States and Laos. Frequent co-authors include Rakesh Kumar, Yi‐Zhou Jiang, Xi Jin, Xin Hu, Ding Ma, Zhi‐Ming Shao, Sujit S. Nair, Yi Xiao, Gen‐Hong Di and Fan Yang. Their work appears in journals such as Journal of Biological Chemistry, Cancer Research, Cancer Letters, Cell Metabolism and Theranostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.